Výsledky vyhledávání
- 1.BENESOVA, B.; DE SANTIS, S.; POLIVKOVA, V.; PECHERKOVA, P.; KRIZKOVA, K.; SUCHANKOVA, P.; MONALDI, C.; KLAMOVA, H.; SRBOVA, D.; ZIZKOVA, H.; HOCHHAUS, A.; SOVERINI, S.; MACHOVA POLAKOVA, K.G Unstable major molecular response as a trigger for next generation sequencing-based BCR::ABL1 mutation testing in chronic myeloid leukemia. American journal of hematology. 2024, vol. 99, no. 4, s. 759-762. ISSN 0361-8609.
- 2.SUCHANKOVA, P.; BENESOVA, A.; PECHERKOVA, P.; POLIVKOVA, V.; KOBLIHOVA, J.; MACHOVA POLAKOVA, K. Detector of somatic point mutations in leukemias resistant to therapy. [Prezentováno: ENBIK national bioinformatic conference. Němčice, 13.6.-15.6.2022.].
- 3.SALMON, M.; WHITE, H.E.; ZIZKOVA, H.; GOTTSCHALK, A.; MOTLOVA, E.; CERVEIRA, N.; COLOMER, D.; CORIU, D.; FRANKE, G.N.; GOTTARDI, E.; IZZO, B.; JURCEK, T.; LION, T.; SCHÄFER, V.; VENTURI, C.; VIGNERI, P.; ZAWADA, M.; ZUNA, J.; HOVORKOVA, L.; KOBLIHOVA, J.; KLAMOVA, H.; STASTNA MARKOVA, M.; SRBOVA, D.; BENESOVA, A.; POLIVKOVA, V.; ZACKOVA, D.; MAYER, J.; ROEDER, I.; GLAUCHE, I.; ERNST, T.; HOCHHAUS, A.; MACHOVA POLAKOVA, K.; CROSS, N.C.P. Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy. Leukemia. 2022, vol. 36, no. 7, s. 1879-1886. ISSN 0887-6924.
- 4.MOCIKOVA, H.; PYTLIK, R.; BENESOVA, K.; ET AL. Peripheral T-cell lymphomas involving the central nervous system: a report from the Czech Lymphoma Study Group Registry. Frontiers in oncology. 2022, vol. 12, no. [May], art. no. 874462. ISSN 2234-943X.
- 5.KOBLIHOVA, J.; POLIVKOVA, V.; BENESOVA, A.; ZIZKOVA H.; CURIK, N.; PEPEK, M.; STOKLOSA T.; STASTNA MARKOVA, M.; KLAMOVA, H.; SRBOVA, D.; MACHOVA POLAKOVA, K. Clonal hematopoiesis with somatic mutations in "AYA" generation of patients with chronic myeloid leukemia. [Prezentováno: 21. pražské hematologické dny: hematologie 2021: post-ASH. Praha, 28.1.-29.1.2021.].
- 6.BENESOVA, A.; POLIVKOVA, V.; PECHERKOVA, P.; KOBLIHOVA, J.; KLAMOVA, H.; SRBOVA, D.; ZIZKOVA, H.; MACHOVA POLAKOVA, K. Do not waste the data: a pipeline for evaluation of BCR-ABL1 kinase domain mutation using individual thresholds. [Prezentováno: 21. pražské hematologické dny: hematologie 2021: post-ASH. Praha, 28.1.-29.1.2021.].
- 7.MACHOVA POLAKOVA, K.; SALMON, M.; ZIZKOVA, H.; GOTTSCHALK, A.; MOTLOVA, E.; JURCEK, T.; ZUNA, J.; HOVORKOVA, L.; KOBLIHOVA, J.; KLAMOVA, H.; STASTNA MARKOVA, M.; SRBOVA, D.; BENESOVA, A.; POLIVKOVA, V.; ET AL. Individual molecular response evaluation on both DNA and mRNA BCR-ABL1 level diminished differences in time to molecular response achievement between CML patients with e13a2 vs e14a2 transcript type. [Prezentováno: 21. pražské hematologické dny: hematologie 2021: post-ASH. Praha, 28.1.-29.1.2021.].
- 8.POLIVKOVA, V.; BENESOVA, A.; ZIZKOVA, H.; KOBLIHOVA, J.; CURIK, N.; MOTLOVA, E.; KLAMOVA, H.; SALEK, C.; MACHOVA POLAKOVA, K.G Sensitivity and reliability of DNA-based mutation analysis by allele-specific digital PCR to follow resistant BCR-ABL1-positive cells. Leukemia. 2021, vol. 35, no. 8, s. 2419-2423. ISSN 0887-6924.
- 9.KOBLIHOVA, J.; POLIVKOVA, V.; BENESOVA, A.; ZIZKOVA, H.; CURIK, N.; PEPEK, M.; STOKLOSA, T.; STASTNA MARKOVA, M.; KLAMOVA, H.; SRBOVA, D.; MACHOVA POLAKOVA, K. Therapy failure of CML patients in „AYA“ generation is frequently associated with the clonal hematopoiesis. [Prezentováno: 22nd annual John Goldman conference on chronic myeloid leukemia: biology and therapy. Mandelieu-La Napoule [virtually], 2.10.-4.10.2020.].
- 10.BENESOVA, A.; POLIVKOVA, V.; PECHERKOVA, P.; KOBLIHOVA, J.; KLAMOVA, H.; SRBOVA, D.; ZIZKOVA, H.; MACHOVA POLAKOVA, K. Do not waste the data: a pipeline for evaluation of BCR-ABL1 kinase domain mutation using individual thresholds. [Prezentováno: 22nd annual John Goldman conference on chronic myeloid leukemia: biology and therapy. Mandelieu-La Napoule [virtually], 2.10.-4.10.2020.].